Latanoprost / Netarsudil Ophthalmic Dosage
Medically reviewed by Drugs.com. Last updated on Sep 19, 2022.
Applies to the following strengths: 0.005%-0.02%
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Intraocular Hypertension
Latanoprost 0.005%-netarsudil 0.02% ophthalmic solution: 1 drop into the affected eye(s) once a day in the evening
- Maximum dose: 1 drop/eye/day
Comment: Administration of other topical ophthalmic drugs to lower intraocular pressure (IOP) should be separated by at least 5 minutes.
Use: Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension
Usual Adult Dose for Glaucoma (Open Angle)
Latanoprost 0.005%-netarsudil 0.02% ophthalmic solution: 1 drop into the affected eye(s) once a day in the evening
- Maximum dose: 1 drop/eye/day
Comment: Administration of other topical ophthalmic drugs to lower intraocular pressure (IOP) should be separated by at least 5 minutes.
Use: Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
Missed doses:
- If a dose is missed, patients should continue with the next dose in the evening.
- The maximum daily dose is 1 drop in the affected eye per day.
Precautions
CONTRAINDICATIONS: None.
Safety and efficacy have not been established in pediatric patients.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- During administration, patients should avoid touching tip of the single-use vial to the eye or any surface.
- Patients who require the use of other drugs to lower IOP should separate their administration by at least 5 minutes.
Storage requirements:
- The manufacturer product information should be consulted.
Patient advice:
- Patients should be instructed to avoid touching the vial tip to the eye or other surfaces.
- Patients who wear contact lenses should remove contact lenses before administration; the lenses may be reinserted at least 15 minutes after administration.
- Patients should be advised to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.
More about latanoprost / netarsudil ophthalmic
- Check interactions
- Compare alternatives
- Reviews (22)
- Side effects
- During pregnancy
- Drug class: ophthalmic glaucoma agents
- En español
Patient resources
- Latanoprost and netarsudil ophthalmic drug information
- Netarsudil and latanoprost (Advanced Reading)
- Netarsudil and Latanoprost
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.